首页> 外文期刊>The Journal of Experomental Medicine >Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease)
【24h】

Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease)

机译:Fcα受体(Cd89)介导免疫球蛋白a(Iga)肾病(伯杰氏病)的发展

获取原文
           

摘要

The pathogenesis of immunoglobulin A (IgA) nephropathy (IgAN), the most prevalent form of glomerulonephritis worldwide, involves circulating macromolecular IgA1 complexes. However, the molecular mechanism(s) of the disease remain poorly understood. We report here the presence of circulating soluble FcαR (CD89)-IgA complexes in patients with IgAN. Soluble CD89 was identified as a glycoprotein with a 24-kD backbone that corresponds to the expected size of CD89 extracellular domains. To demonstrate their pathogenic role, we generated transgenic (Tg) mice expressing human CD89 on macrophage/monocytes, as no CD89 homologue is found in mice. These mice spontaneously developed massive mesangial IgA deposition, glomerular and interstitial macrophage infiltration, mesangial matrix expansion, hematuria, and mild proteinuria. The molecular mechanism was shown to involve soluble CD89 released after interaction with IgA. This release was independent of CD89 association with the FcRγ chain. The disease was induced in recombination activating gene (RAG)2?/? mice by injection of serum from Tg mice, and in severe combined immunodeficiency (SCID)-Tg mice by injection of patients' IgA. Depletion of soluble CD89 from serum abolished this effect. These results reveal the key role of soluble CD89 in the pathogenesis of IgAN and provide an in vivo model that will be useful for developing new treatments.
机译:免疫球蛋白A(IgA)肾病(IgAN)是全球范围内最普遍的肾小球肾炎的发病机制,涉及循环中的大分子IgA1复合物。然而,对该疾病的分子机制仍知之甚少。我们在这里报告了IgAN患者中循环可溶性FcαR(CD89)-IgA复合物的存在。可溶性CD89被鉴定为具有24-kD主链的糖蛋白,其对应于CD89细胞外结构域的预期大小。为了证明其致病作用,我们生成了在巨噬细胞/单核细胞上表达人CD89的转基因(Tg)小鼠,因为在小鼠中未发现CD89同源物。这些小鼠自发形成大量的肾小球系膜IgA沉积,肾小球和间质巨噬细胞浸润,肾小球系膜基质扩张,血尿和轻度蛋白尿。分子机制显示与IgA相互作用后释放的可溶性CD89。该释放独立于CD89与FcRγ链的结合。该疾病是由重组激活基因(RAG)2α/β诱导的。通过注射Tg小鼠的血清来治疗小鼠,以及通过注射患者的IgA来治疗严重的联合免疫缺陷(SCID)-Tg小鼠。血清中可溶性CD89的消耗消除了这种作用。这些结果揭示了可溶性CD89在IgAN发病机理中的关键作用,并提供了可用于开发新疗法的体内模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号